Rakovina Therapeutics Secures $4 Million to Boost AI-Driven Oncology Innovations
Rakovina Therapeutics Inc. has secured $4 million in strategic financing to accelerate its growth in the US and enhance its AI-powered cancer therapies.
2 minutes to read